Exploring how a specific chemical modification affects the immune system development in newborns
Understanding the role of histone3 lysine4 trimethylation in neontal innate immune development under normal and inflammatory conditions
This study looks at how a specific change in genes affects the immune system of newborns, helping us understand why babies are more prone to infections and how we might improve their ability to fight off illnesses.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Iowa NIH-funded |
| Lab location | 1 site (Iowa City, United States) |
| Project ID | NIH-10765738 on NIH RePORTER |
What this research studies
This research investigates how histone 3 lysine 4 trimethylation influences the development of the innate immune system in neonates, particularly under normal and inflammatory conditions. By examining the differences in immune responses between neonates and adults, the study aims to understand the mechanisms that make newborns more susceptible to infections. The research focuses on the role of monocytes and macrophages, which are crucial for initiating immune responses, and how their gene expression changes as a child matures. The findings could provide insights into improving immune responses in newborns, potentially leading to better prevention and treatment strategies for neonatal infections.
Who could benefit from this research
Good fit: Ideal candidates for this research include newborns and infants, particularly those at risk for infections due to their developing immune systems.
Not a fit: Patients who are adults or those with fully developed immune systems may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for preventing and treating infections in newborns, ultimately reducing neonatal mortality rates.
How similar studies have performed: While the specific focus on histone modifications in neonatal immune development is relatively novel, similar research has shown promising results in understanding immune responses in other populations.
Where this research is happening
Iowa City, United States
- University of Iowa — Iowa City, United States (Active)
Researchers
- Principal investigator: Bermick, Jennifer — University of Iowa
- Study coordinator: Bermick, Jennifer
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.